News
SydLab One by Nagi Bioscience hits the market
Nagi Bioscience releases an end-to-end automated device to screen drugs, chemicals and others substances on micro-organisms. Swiss EPFL spin-off Nagi Bioscience, a biotech start-up specialized in developing innovative alternatives to animal testing, announces today the commercialization of their first full product solution: SydLab One. Under the premise of unlocking the whole potential of micro-organisms as…
Read MoreHorizon Europe for Swiss Researchers
Swiss entities can participate in most Horizon Europe calls. Funding is provided by the Swiss government as long as Switzerland is not associated to the programme. The European programme for research and innovation, ‘Horizon Europe’, has a total of €95.5 billion with which to fund ground-breaking research that will impact society at all…
Read MoreLudwig Cancer Research and Canton of Vaud Partner to Build a Research Centre
The new centre will be dedicated to synthetic immunotherapy and immune engineering on the Biopôle site in Epalinges. The building covers more than 9,000 square meters; the future premises will be divided into two main areas, one dedicated to hosting research groups and the other to various platforms, including tools for cell imaging, cytometry…
Read MoreErwin Böttinger is the new Wyss Center Geneva CEO
The Executive Board of the Wyss Center for Bio and Neuroengineering, a non-profit research center, is pleased to announce the appointment of Prof. Dr. med. Erwin Böttinger as its new Chief Executive Officer (CEO). Prof. Böttinger has a longstanding track record in personalized medicine, with emphasis on genomics and digital technologies. Before joining the…
Read MoreLonza completed its latest drug manufacturing line in Visp
The new line will support customers with a range of drug product manufacturing needs for both clinical and commercial supply. Set in a 1,200 sqm cGMP facility, it includes a state-of-the-art liquid and lyophilized vial filling isolator line for multiple modalities that fulfils the GMP Annex 1 requirement for the manufacture of sterile products1.…
Read MoreW.A. de Vigier Awards 2023: 7 Western Switzerland Life Sciences Startups Selected
15 startups were selected among 300 projects. 5 of them are set to win CHF 100,000. The Award Ceremony is scheduled on 20 June 2023. The Top 15 will now be further assessed through in-depth interviews with the foundation board as well as expert reports. The Top 10 are subsequently selected during two presentation…
Read MoreAn Obesity Center opens at the CHUV
The creation of an Obesity Center at the CHUV enables the teams of Dr. Lucie Favre, head of the Obesity Consultation (Endocrinology Service), and Dr. Styliani Mantziari, head of the Bariatric Surgery Unit (Visceral Surgery Service), to combine their expertise in order to offer multidisciplinary and personalized care to patients who suffer from obesity. …
Read MoreAlithea Genomics receives CHF 500,000 from FIT
The EPFL spin-off is active in high-throughput RNA sequencing, used to examine gene expression and discover new biomarkers and drugs. The Foundation for Technological Innovation (FIT) has chosen to give the company a Tech Growth loan of CHF 500,000. Since the Covide-19 pandemic, RNA sequencing is widely used in for fundamental research studies,…
Read MoreLunaphore raises CHF 40 million in Series D1 funding
The Swiss startup plans to use the funding to strengthen its growing portfolio offering in spatial biology. Lunaphore Technologies S.A is a Vaud-based spatial biology company, building multiplex immunofluorescence & IHC solutions for discovery and immuno-oncology research. The startup announced that it has completed CHF 40M in Series D1 funding. The round was…
Read MoreA VR training programme for medical students supported by Innosuisse
Viva VOsCE is a revolutionary project aiming at transforming medical education through harnessing the power of Virtual Reality (VR) technology. The project is being conducted in partnership with the Geneva University Hospitals (HUG) and the University of Bern, with ORamaVR S.A. as implementation partner. Objective Structured Clinical Examinations (OSCE) are critical for the practical…
Read More